Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
A completed clinical trial update assessing structural brain imaging and cognitive function in adult stem cell transplant recipients treated…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 trial evaluating early allogeneic blood stem cell transplantation in high-risk acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML) [Phase 1]
A Phase 1 study of KX2-391 in elderly patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
This Phase 2 trial updates romidepsin for relapsed or refractory acute myeloid leukemia, covering several AML subtypes defined by cytogeneti…
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia [Phase 1]
This Phase 1 clinical trial update reports on the combination of oblimersen (Genasense) with cytarabine and daunorubicin in older adults wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
Completed Phase 1 trial of GTI-2040 in adults with relapsed or high-risk acute leukemias, myelodysplastic syndromes, or refractory/blastic p…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Treosulfan-based Conditioning for Transplantation in AML/MDS [Phase 2]
Phase 2 trial evaluating treosulfan-based conditioning for transplantation in acute myeloid leukemia and myelodysplastic syndrome. The study…
-
CLINICAL_TRIALS trial_result · 2015-11-24Clinical Trial Update: A Study Of Panobinostat In Children With Refractory Hematologic Malignancies [Phase 1]
This update reports the completion of a Phase 1 pediatric study evaluating panobinostat in children with refractory hematologic malignancies…
-
CLINICAL_TRIALS trial_result · 2015-11-23Clinical Trial Update: Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 safety and tolerability study of SG2000 for advanced chronic lymphocytic leukemia and acute myeloid leukemia has been terminated…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML [Phase 1]
Phase 1 dose-finding study evaluating decitabine maintenance after bone marrow transplant in higher-risk myelodysplastic syndrome and MDS/AM…
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Non-interventional Study With Azacitidin (Vidaza®)
This document reports a completed non-interventional study of azacitidine (Vidaza) in patients with myelodysplastic syndromes, acute myeloid…
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia [Phase 2]
Phase 2 trial evaluating nebulized amphotericin B lipid complex for invasive aspergillosis in pediatric patients with acute leukemia has com…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 study evaluating the combination of clofarabine and gemtuzumab ozogamicin for relapsed or refractory acute myeloid leukemia has been…
-
CLINICAL_TRIALS trial_result · 2015-10-09Clinical Trial Update: A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission [Phase 1]
Phase 1 study of CSL362 for CD123-positive acute myeloid leukemia in remission has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating clofarabine as salvage therapy for relapsed or refractory acut…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients [Phase 1]
A Phase 1 trial evaluating maintenance therapy with decitabine in elderly patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
This is an update on a completed trial assessing transplant-related mortality in patients undergoing peripheral blood stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial investigating gemcitabine and mitoxantrone in relapsed acute myeloid leukemia; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit [Phase 2]
Phase 2 clinical trial evaluating hematopoietic stem cell transplantation using a CD34-selected mismatched related donor plus one umbilical …
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML [Phase 2]
A Phase 2 trial comparing azacitidine versus conventional chemotherapy as consolidation therapy in elderly patients with acute myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Azacitidine and Lenalidomide for Acute Myeloid Leukemia [Phase 1, Phase 2]
The document reports completion and results posting for a Phase 1/2 trial of azacitidine plus lenalidomide in adults with acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia [Phase 1]
A Phase 1 study evaluating a combination of azacitidine, mitoxantrone hydrochloride, and etoposide in older patients with poor-prognosis acu…
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide [NA]
A completed pilot clinical trial evaluated immunomonitoring of natural killer cells in patients with acute myeloid leukemia or myelodysplast…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
This entry reports the completion of a Phase 1 trial evaluating the combination of bortezomib, mitoxantrone, etoposide, and cytarabine in ad…